Can you take Imodium with Wegovy? Diarrhoea, semaglutide and what the evidence says

The misconception worth correcting: diarrhoea on Wegovy doesn't mean something has gone wrong

A lot of people starting Wegovy assume that loose stools mean the medicine isn't agreeing with them and that they should stop. That's rarely the right conclusion. Diarrhoea, alongside nausea and constipation, sits in the normal gastrointestinal profile of semaglutide. The NHS medicines page for semaglutide lists it as a common side effect, meaning it affects more than one in ten people at some point during treatment.

The mechanism is straightforward: semaglutide slows gastric emptying and affects gut motility. Your digestive system is adjusting to a significant change in how quickly food moves through it. For many people, loose stools appear in the first two to four weeks after starting or after stepping up to the next dose, then settle. The body, given time, recalibrates. Stopping the medicine during this window means missing the benefit while absorbing the disruption.

That said, "common and temporary" doesn't mean "ignore it". Frequent diarrhoea carries a dehydration risk that is specifically relevant on a GLP-1 medicine, because if you are also experiencing any nausea or reduced appetite, fluid intake can fall at exactly the wrong moment. Sip water consistently, even when you don't feel thirsty, and reduce fatty or spicy food temporarily while your gut settles.

The timing often catches people off guard: a dose increase at the start of the month, a holiday booking, a week before a big event. If you know an increase is coming, planning lighter meals around it is sensible, a question worth raising with your prescriber.

Where Imodium fits in, and where it doesn't

Loperamide works by slowing intestinal contractions, which is one reason it addresses the symptom rather than the cause. On Wegovy, the cause is the medicine's effect on gut motility, so loperamide is, in a sense, partially counteracting that effect locally in the gut. There is no pharmacokinetic interaction between loperamide and semaglutide documented in the prescribing literature. Short-term use for practical relief (before a long journey, say, or a day when being away from a bathroom isn't an option) is broadly regarded by clinicians as reasonable.

What loperamide isn't suited for is ongoing or heavy use. If you are reaching for it every few days during the first month, that's a signal to contact your prescriber rather than continue self-managing. The same applies if the diarrhoea is accompanied by cramping that feels more intense than general gut discomfort, blood in stools, or fever. These symptoms sit outside what Wegovy typically produces and need direct clinical attention.

Imodium also doesn't address dehydration. If symptoms are frequent, oral rehydration salts are more important than an antidiarrhoeal. You can read about how other supplements interact with treatment (including magnesium and Wegovy) since magnesium supplements can worsen loose stools and timing matters on semaglutide.

For people who use semaglutide alongside other medicines, the interaction picture can be more complex. Our page on semaglutide and lithium is one example of where additional care applies, a reminder that the complete medication list always belongs in the consultation.

When diarrhoea on Wegovy needs more than self-care

Most semaglutide-related diarrhoea resolves within a few weeks without any treatment beyond staying hydrated and adjusting what you eat. A minority of people find it persists or remains disruptive enough to affect daily life. In that case, the right move is a conversation with the prescriber who manages your Wegovy treatment, not necessarily stopping the medicine, but possibly adjusting the titration schedule or exploring whether something else is contributing.

There is one symptom pattern that requires prompt medical assessment: severe or persistent abdominal pain, particularly pain that radiates to the back, with or without vomiting. This falls into the territory of pancreatitis, which (while uncommon) is a known risk with GLP-1 medicines. The MHRA issued a Drug Safety Update in January 2026 reinforcing this point for the class as a whole. Loperamide will not help here, and waiting to see if it passes is not the right call. Go to your GP or, if symptoms are acute, seek urgent care.

Side effects that affect your skin, mood, or other body systems while on semaglutide are worth tracking too, some readers find our page on Wegovy and skin changes useful for understanding the broader picture. And if you have a condition that adds complexity to semaglutide treatment, our page on MS and Wegovy shows how a nuanced clinical conversation makes the difference.

You can also find general answers to common Wegovy questions on our FAQs page, or get in touch with our support team if you have a question about your current treatment. If you are considering starting Wegovy and want to understand the full cost of private treatment, our page on what Wegovy costs in the UK explains what a legitimate price includes. Wegovy is a prescription-only medicine, a GPhC-registered prescriber assesses your suitability before anything is dispensed. If you would like to start that process, our clinical team is available seven days a week.